Overview
BPC-157 is a synthetic pentadecapeptide derived from a larger endogenous gastric protein complex commonly referred to as Body Protection Compound (BPC). This defined 15-amino acid sequence has been examined in preclinical research systems for its molecular stability and biochemical activity profile.
Within laboratory environments, BPC-157 is utilized as a research peptide to investigate cellular migration, extracellular matrix dynamics, angiogenic signaling pathways, oxidative stress modulation, and cytoskeletal organization. All available data are derived exclusively from controlled in-vitro studies and in-vivo animal research models.
Biochemical Characteristics
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Formula: C₆₂H₉₈N₁₆O₂₂
- Molecular Weight: 1419.556 g/mol
- PubChem CID: 108101
BPC-157 is a linear peptide that does not contain disulfide bonds. Its proline-rich structure contributes to conformational rigidity and reduced susceptibility to enzymatic degradation, supporting relative stability in aqueous experimental systems.
Research Applications
BPC-157 is supplied exclusively for laboratory research use and has been employed in controlled experimental studies examining:
- Fibroblast proliferation and directional migration
- Endothelial cell growth and angiogenic pattern formation
- Extracellular matrix deposition and remodeling
- Cytoskeletal organization and focal adhesion signaling
- Oxidative stress marker modulation in animal models
- Nitric oxide–associated biochemical pathways
All applications are confined to non-clinical research systems designed to explore fundamental biological mechanisms.
Pathway & Mechanistic Context
Mechanistic investigations describe BPC-157 as a modulator of signaling pathways involved in cellular motility and vascular organization. Experimental findings suggest interactions with VEGFR2-associated signaling cascades and downstream nitric oxide–related molecular processes.
Additional in-vitro data report phosphorylation changes in focal adhesion signaling proteins associated with cytoskeletal anchoring and directional cell migration. These observations support its use as a molecular probe in studies of cytoskeletal remodeling within controlled laboratory environments.
Preclinical Research Summary
Published preclinical literature documents investigations of BPC-157 across multiple experimental platforms. In rodent models, the peptide has been studied in research examining vascular recruitment, gastrointestinal tissue structure, and connective tissue remodeling under controlled laboratory conditions.
Additional exploratory research in avian and invertebrate systems has evaluated peptide stability and tissue-level stress responses, contributing to broader mechanistic insights into conserved biological signaling pathways.
No clinical conclusions or therapeutic claims are expressed or implied.
Form & Analytical Testing
BPC-157 is supplied as a lyophilized peptide manufactured via solid-phase peptide synthesis. Each production lot undergoes analytical verification using:
- HPLC — purity profiling and lot consistency
- Mass Spectrometry — molecular identity confirmation
Supporting analytical documentation is provided with each batch to promote reproducibility and consistency in laboratory research applications.
Purity & Quality
- ≥99% Purity — HPLC Verified
- Independently tested by accredited third-party laboratory
- Certificate of Analysis (CoA) available for every batch
Research Use Only (RUO) Notice
All products are furnished strictly for in-vitro laboratory research use only. "In-vitro" refers to studies conducted outside of a living organism in controlled laboratory conditions. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.
